|
2024
|
Invention
|
Substituted nicotinimide inhibitors of btk for treating cancer.
Compounds of Formula I, as shown... |
|
2023
|
Invention
|
Substituted nicotinimide inhibitors of btk for treating cancer. Compounds of Formula I, as shown ... |
|
2021
|
Invention
|
Heterocyclic compounds for mediating tyrosine kinase 2 activity. Heterocyclic compounds shown in ... |
|
2019
|
Invention
|
Substituted nicotinimide inhibitors of btk and their preparation and use in the treatment of canc... |
|
2017
|
Invention
|
Heterocyclic compounds as fgfr inhibitors. The present invention relates to a heterocyclic compou... |
|
|
Invention
|
Heterocyclic compound as fgfr inhibitor. A class of heterocyclic compounds, a pharmaceutical comp... |
|
2014
|
Invention
|
Substituted nicotinamide inhibitors of btk and their preparation and use in the treatment of canc... |
